FDA — authorised 3 August 2017
- Application: NDA209394
- Marketing authorisation holder: ABBVIE
- Status: supplemented
🇺🇸 Mavyret in United States
FDA authorised Mavyret on 3 August 2017
Marketing authorisations
FDA — authorised 10 June 2021
- Application: NDA215110
- Marketing authorisation holder: ABBVIE
- Status: approved
FDA
- Status: approved
Other Other approved in United States
Frequently asked questions
Is Mavyret approved in United States?
Yes. FDA authorised it on 3 August 2017; FDA authorised it on 10 June 2021; FDA has authorised it.
Who is the marketing authorisation holder for Mavyret in United States?
ABBVIE holds the US marketing authorisation.